Compounds and method of treating psychosis and schizophrenia

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Other Related Categories

549283, 549378, A61K 3135, C07D31102, C07D31912

Type

Patent

Status

active

Patent number

059169141

Description

ABSTRACT:
This invention relates to compounds that are antagonists of dopamine D4 receptors, and to methods of treating psychosis and schizophrenia using a compound that is an antagonist of dopamine D4 receptors.

REFERENCES:
patent: 2547365 (1951-04-01), Bock et al.
patent: 2599001 (1952-06-01), Kerwin et al.
patent: 3154581 (1964-10-01), Dice
patent: 3159676 (1964-12-01), Spickett et al.
patent: 3192253 (1965-06-01), Boscott et al.
patent: 3663712 (1972-05-01), Schmelling et al.
patent: 4010280 (1977-03-01), Maruyama et al.
patent: 5760050 (1998-06-01), Connor et al.
J. Augstein, et al., J Med Chem, "Some Cardiovascular Effects of a Series of Aryloxyalkylamines," 1965, 8, 356.
L.H. Smith, et al, J Med Chem, ".beta.-Adrenergic Blocking Agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-Alkoxyalkylamino-3-phenoxy-2-propanols," 1977, 20:12, 1653-1656.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compounds and method of treating psychosis and schizophrenia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and method of treating psychosis and schizophrenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and method of treating psychosis and schizophrenia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1375688

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.